BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8282820)

  • 21. Patterns of positive selection of the myogenic regulatory factor gene family in vertebrates.
    Zhao X; Yu Q; Huang L; Liu QX
    PLoS One; 2014; 9(3):e92873. PubMed ID: 24651579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
    Maira SM; Wurtz JM; Wasylyk B
    EMBO J; 1996 Nov; 15(21):5849-65. PubMed ID: 8918463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors.
    MacQuarrie KL; Yao Z; Fong AP; Diede SJ; Rudzinski ER; Hawkins DS; Tapscott SJ
    Mol Cell Biol; 2013 Feb; 33(4):773-84. PubMed ID: 23230269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of v-src alters the expression of myogenic regulatory factor genes.
    Yoon H; Boettiger D
    Oncogene; 1994 Mar; 9(3):801-7. PubMed ID: 8108122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly conserved asparagine in the basic domain of Myc is dispensable for DNA binding, transformation, and apoptosis.
    Bodis S; Hemesath T; Fisher DE
    Biochem Mol Med; 1997 Apr; 60(2):102-7. PubMed ID: 9169089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA.
    Grad JM; Dai JL; Wu S; Burnstein KL
    Mol Endocrinol; 1999 Nov; 13(11):1896-911. PubMed ID: 10551783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Xenopus MyoD transcription by members of the MEF2 protein family.
    Wong MW; Pisegna M; Lu MF; Leibham D; Perry M
    Dev Biol; 1994 Dec; 166(2):683-95. PubMed ID: 7813786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The four human muscle regulatory helix-loop-helix proteins Myf3-Myf6 exhibit similar hetero-dimerization and DNA binding properties.
    Braun T; Arnold HH
    Nucleic Acids Res; 1991 Oct; 19(20):5645-51. PubMed ID: 1945842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of members of the myf gene family in human rhabdomyosarcomas.
    Clark J; Rocques PJ; Braun T; Bober E; Arnold HH; Fisher C; Fletcher C; Brown K; Gusterson BA; Carter RL
    Br J Cancer; 1991 Dec; 64(6):1039-42. PubMed ID: 1764365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.
    Yang Z; MacQuarrie KL; Analau E; Tyler AE; Dilworth FJ; Cao Y; Diede SJ; Tapscott SJ
    Genes Dev; 2009 Mar; 23(6):694-707. PubMed ID: 19299559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors.
    Bouché M; Senni MI; Grossi AM; Zappelli F; Polimeni M; Arnold HH; Cossu G; Molinaro M
    Exp Cell Res; 1993 Sep; 208(1):209-17. PubMed ID: 8395398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.
    Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Furihata M; Ohtsuki Y
    Int J Oncol; 2000 Jul; 17(1):119-25. PubMed ID: 10853028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.
    Chen B; Dias P; Jenkins JJ; Savell VH; Parham DM
    Am J Pathol; 1998 Apr; 152(4):1071-9. PubMed ID: 9546368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a muscle factor related to MyoD in a fish species.
    Rescan PY; Gauvry L; Paboeuf G; Fauconneau B
    Biochim Biophys Acta; 1994 Jun; 1218(2):202-4. PubMed ID: 8018722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.
    Kohsaka S; Shukla N; Ameur N; Ito T; Ng CK; Wang L; Lim D; Marchetti A; Viale A; Pirun M; Socci ND; Qin LX; Sciot R; Bridge J; Singer S; Meyers P; Wexler LH; Barr FG; Dogan S; Fletcher JA; Reis-Filho JS; Ladanyi M
    Nat Genet; 2014 Jun; 46(6):595-600. PubMed ID: 24793135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial sequence of porcine MYF6 gene, its comparative analysis and a novel polymorphism of the region coding for the basic domain.
    Wyszyńska-Koko J; Kuryl J; Flisikowski K
    Biochem Genet; 2004 Dec; 42(11-12):411-8. PubMed ID: 15587984
    [No Abstract]   [Full Text] [Related]  

  • 37. Genome-wide binding of the basic helix-loop-helix myogenic inhibitor musculin has substantial overlap with MyoD: implications for buffering activity.
    MacQuarrie KL; Yao Z; Fong AP; Tapscott SJ
    Skelet Muscle; 2013 Nov; 3(1):26. PubMed ID: 24175993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the origin and the genetic basis of rhabdomyosarcomas.
    Soleimani VD; Rudnicki MA
    Cancer Cell; 2011 Feb; 19(2):157-9. PubMed ID: 21316595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
    Rekhi B; Upadhyay P; Ramteke MP; Dutt A
    Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.